@Sorepocket, I read and appreciated your post & points. I can understand in ‘normal’ times cost is an important consideration. I wonder though if it’s just not a case of time in hospital but also the effects of long Covid? The ongoing rehabilitation of people is going to be immense, unlike anything we have witnessed before on a world scale. There also seems to be cognitive & psychological symptoms that, to be honest, I don’t think society has experienced to such a high degree and been aware of at the time (would have occurred during war & post war times but as a society, we were not enlightened enough to probably acknowledge & deal with such illnesses).
If Remestemcel-L can stop such symptoms from happening, the immediate outlay, IMO, will be a most long term cost effective strategy.
-
- There are more pages in this discussion • 3,610 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $2.956B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.35 | $2.15 | $30.94M | 13.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 75954 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.32 | 10350 | 2 |
View Market Depth
| Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |